
PATIENT SELECTION & ELIGIBILITY CRITERIA
Identify ten (10) patients that may benefit from 0.5 mg once daily Colchicine (MyinflaTM ER) and meet the DEMONSTRATE program eligibility criteria.
Data entry is de-identified and all management decisions are the discretion of the participating physician.
Eligibility Criteria:
-
Age > 18 years
-
Prior Myocardial Infarction
-
Not currently treated with Colchicine
-
No contraindications to Colchicine*
-
Ability to optimize patient's secondary prevention management within the next month (e.g. regularly scheduled appointment date or ability to schedule virtual / in person follow-up visit)
-
Unencumbered access to Colchicine (Myinfla ER):
-
Private insurance
-
Ability to cover out of pocket**
-
​
* Contraindications to Colchicine: strong P-glycoprotein (P-gp) inhibitors or strong CYP3A4 inhibitors, severe renal impairment (eGFR < 30 mL/min), severe hepatic impairment, existing blood dyscrasias.
​
** Myinfla’s current list price in Ontario is ≈ $0.50 per day